These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30226443)

  • 21. Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated Thyroid Cancer.
    Miller JE; Al-Attar NC; Brown OH; Shaughness GG; Rosculet NP; Avram AM; Hughes DT
    Thyroid; 2018 May; 28(5):593-600. PubMed ID: 29562827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging
    Okuyucu K; Ince S; Alagoz E; Emer O; San H; Balkan E; Ayan A; Meric C; Haymana C; Acıkel C; Gunalp B; Karacalioglu AO; Arslan N
    Hell J Nucl Med; 2016; 19(3):208-217. PubMed ID: 27824959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT.
    Seo JH; Lee SW; Ahn BC; Lee J
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):558-63. PubMed ID: 19744107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The added benefit of a dedicated neck F-18 FDG PET-CT imaging protocol in patients with suspected recurrent differentiated thyroid carcinoma.
    Davison JM; Stocker DJ; Montilla-Soler JL; Jurgens JS; Allen TW; Holley TS; Stack AL
    Clin Nucl Med; 2008 Jul; 33(7):464-8. PubMed ID: 18580230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
    Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
    Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
    Lamartina L; Borget I; Mirghani H; Al Ghuzlan A; Berdelou A; Bidault F; Deandreis D; Baudin E; Travagli JP; Schlumberger M; Hartl DM; Leboulleux S
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1020-1031. PubMed ID: 28359102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
    Na SJ; Yoo IeR; O JH; Lin C; Lin Q; Kim SH; Chung SK
    Ann Nucl Med; 2012 Jan; 26(1):26-34. PubMed ID: 21971605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis.
    Khiewvan B; Nopmaneejumruslers C; Pusuwan P; Tuchinda P; Tojinda N; Ubolnuch K
    J Med Assoc Thai; 2013 Oct; 96(10):1350-64. PubMed ID: 24350419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence.
    Banerjee M; Wiebel JL; Guo C; Gay B; Haymart MR
    BMJ; 2016 Jul; 354():i3839. PubMed ID: 27443325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer.
    Chinn SB; Zafereo ME; Waguespack SG; Edeiken BS; Roberts DB; Clayman GL
    Thyroid; 2017 Oct; 27(10):1291-1299. PubMed ID: 28806882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography-computed tomography evaluation for recurrent differentiated thyroid carcinoma.
    Makeieff M; Burcia V; Raingeard I; Eberlé MC; Cartier C; Garrel R; Crampette L; Guerrier B
    Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Oct; 129(5):251-6. PubMed ID: 22818209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
    Frilling A; Tecklenborg K; Görges R; Weber F; Clausen M; Broelsch EC
    Ann Surg; 2001 Dec; 234(6):804-11. PubMed ID: 11729387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity.
    Biermann M; Kråkenes J; Brauckhoff K; Haugland HK; Heinecke A; Akslen LA; Varhaug JE; Brauckhoff M
    Acta Radiol; 2015 Nov; 56(11):1350-60. PubMed ID: 25770086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131).
    Coburn M; Teates D; Wanebo HJ
    Ann Surg; 1994 Jun; 219(6):587-93; discussion 593-5. PubMed ID: 8203968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer.
    Kebebew E; Kikuchi S; Duh QY; Clark OH
    Arch Surg; 2000 Aug; 135(8):895-901. PubMed ID: 10922248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Follow-Up Strategy for Patients with an Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma: Less Is Better.
    Jeon MJ; Kim M; Park S; Oh HS; Kim TY; Kim WB; Shong YK; Kim WG
    Thyroid; 2018 Feb; 28(2):187-192. PubMed ID: 29179642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients: a retrospective study of a large clinical series.
    Conzo G; Calò PG; Sinisi AA; De Bellis A; Pasquali D; Iorio S; Tartaglia E; Mauriello C; Gambardella C; Cavallo F; Medas F; Polistena A; Santini L; Avenia N
    Surgery; 2014 Jun; 155(6):998-1005. PubMed ID: 24856120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data.
    Vural GU; Akkas BE; Ercakmak N; Basu S; Alavi A
    Clin Nucl Med; 2012 Oct; 37(10):953-9. PubMed ID: 22899202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computed tomography complements ultrasound for the differential diagnosis of traumatic neuroma from recurrent tumor in patients with postoperative thyroid cancer.
    Lee JY; Kim JH; Yeon EK; Hwang I; Yoo RE; Kang KM; Yun TJ; Choi SH; Sohn CH
    Eur Radiol; 2022 Apr; 32(4):2760-2768. PubMed ID: 34665316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioguided surgery of parathyroid adenomas and recurrent thyroid cancer using the "low sestamibi dose" protocol.
    Rubello D; Fig LM; Casara D; Piotto A; Boni G; Pelizzo MR; Shapiro B; Sandrucci S; Gross MD; Mariani G;
    Cancer Biother Radiopharm; 2006 Jun; 21(3):194-205. PubMed ID: 16918295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.